FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019164040> ?p ?o ?g. }

• W2019164040 endingPage "4968" @default.
• W2019164040 startingPage "4968" @default.
• W2019164040 abstract "To study the management and outcome of children with extrahepatic portal vein obstruction (EHPVO) in a whole country population.A nationwide multicenter retrospective case series of children with EHPVO was conducted. Data on demographics, radiographic studies, laboratory workup, endoscopic and surgical procedures, growth and development, were extracted from the patients' charts. Characteristics of clinical presentation, etiology of EHPVO, management and outcome were analyzed.Thirty patients, 13 males and 17 females, 19 (63.3%) Israeli and 11 (36.7%) Palestinians, were included in the analysis. Age at presentation was 4.8 ± 4.6 years, and mean follow-up was 4.9 ± 4.3 years. Associated anomalies were found in 4 patients. The incidence of EHPVO in Israeli children aged 0-14 years was 0.72/million. Risk factors for EHPVO were detected in 13 (43.3%) patients, including 9 patients (30%) with perinatal risk factors, and 4 patients (13.3%) with prothrombotic states: two had low levels of protein S and C, one had lupus anticoagulant, and one was homozygous for methyltetrahydrofolate reductase mutations. In 56.6% of patients, no predisposing factors were found. The most common presenting symptoms were an incidental finding of splenomegaly (43.3%), and upper gastrointestinal bleeding (40%). No differences were found between Israeli and Palestinian children with regard to age at presentation, etiology and clinical symptoms. Bleeding occurred in 18 patients (60%), at a median age of 3 years. Sclerotherapy or esophageal banding was performed in 20 patients. No sclerotherapy complications were reported. Portosystemic shunts were performed in 11 patients (36.6%), at a median age of 11 (range 3-17) years: splenorenal in 9, mesocaval in 1, and a meso-Rex shunt in 1 patient. One patient underwent splenectomy due to severe pancytopenia. Patients were followed up for a median of 3 (range 0.5-15) years. One patient died aged 3 years due to mucopolysaccharidase deficiency type III. None of the patients died due to gastrointestinal bleeding.EHPVO is a rare disorder. The etiological factors are still mostly unknown, and the endoscopic and surgical treatment options ensure a good long-term prognosis." @default.
• W2019164040 created "2016-06-24" @default.
• W2019164040 creator A5021657149 @default.
• W2019164040 creator A5026843306 @default.
• W2019164040 creator A5034328678 @default.
• W2019164040 creator A5050539641 @default.
• W2019164040 creator A5060614026 @default.
• W2019164040 creator A5067021137 @default.
• W2019164040 creator A5067935814 @default.
• W2019164040 creator A5086781425 @default.
• W2019164040 date "2010-01-01" @default.
• W2019164040 modified "2023-10-03" @default.
• W2019164040 title "Etiology and long-term outcome of extrahepatic portal vein obstruction in children" @default.
• W2019164040 cites W1963827724 @default.
• W2019164040 cites W1983564602 @default.
• W2019164040 cites W1991452357 @default.
• W2019164040 cites W1991671828 @default.
• W2019164040 cites W1996385406 @default.
• W2019164040 cites W2000179823 @default.
• W2019164040 cites W2004579725 @default.
• W2019164040 cites W2022899744 @default.
• W2019164040 cites W2030006942 @default.
• W2019164040 cites W2038729432 @default.
• W2019164040 cites W2058004200 @default.
• W2019164040 cites W2058122407 @default.
• W2019164040 cites W2079025481 @default.
• W2019164040 cites W2089272551 @default.
• W2019164040 cites W2098852927 @default.
• W2019164040 cites W2119234373 @default.
• W2019164040 cites W2138507596 @default.
• W2019164040 cites W2144664431 @default.
• W2019164040 cites W2303797705 @default.
• W2019164040 cites W2398450246 @default.
• W2019164040 cites W3005932272 @default.
• W2019164040 cites W368475356 @default.
• W2019164040 doi "https://doi.org/10.3748/wjg.v16.i39.4968" @default.
• W2019164040 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2957606" @default.
• W2019164040 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20954284" @default.
• W2019164040 hasPublicationYear "2010" @default.
• W2019164040 type Work @default.
• W2019164040 sameAs 2019164040 @default.
• W2019164040 citedByCount "61" @default.
• W2019164040 countsByYear W20191640402012 @default.
• W2019164040 countsByYear W20191640402013 @default.
• W2019164040 countsByYear W20191640402014 @default.
• W2019164040 countsByYear W20191640402015 @default.
• W2019164040 countsByYear W20191640402016 @default.
• W2019164040 countsByYear W20191640402017 @default.
• W2019164040 countsByYear W20191640402018 @default.
• W2019164040 countsByYear W20191640402019 @default.
• W2019164040 countsByYear W20191640402020 @default.
• W2019164040 countsByYear W20191640402021 @default.
• W2019164040 countsByYear W20191640402022 @default.
• W2019164040 countsByYear W20191640402023 @default.
• W2019164040 crossrefType "journal-article" @default.
• W2019164040 hasAuthorship W2019164040A5021657149 @default.
• W2019164040 hasAuthorship W2019164040A5026843306 @default.
• W2019164040 hasAuthorship W2019164040A5034328678 @default.
• W2019164040 hasAuthorship W2019164040A5050539641 @default.
• W2019164040 hasAuthorship W2019164040A5060614026 @default.
• W2019164040 hasAuthorship W2019164040A5067021137 @default.
• W2019164040 hasAuthorship W2019164040A5067935814 @default.
• W2019164040 hasAuthorship W2019164040A5086781425 @default.
• W2019164040 hasBestOaLocation W20191640401 @default.
• W2019164040 hasConcept C126322002 @default.
• W2019164040 hasConcept C137627325 @default.
• W2019164040 hasConcept C141071460 @default.
• W2019164040 hasConcept C167135981 @default.
• W2019164040 hasConcept C187212893 @default.
• W2019164040 hasConcept C2777214474 @default.
• W2019164040 hasConcept C2778230777 @default.
• W2019164040 hasConcept C2778808290 @default.
• W2019164040 hasConcept C2908647359 @default.
• W2019164040 hasConcept C71924100 @default.
• W2019164040 hasConcept C90924648 @default.
• W2019164040 hasConcept C99454951 @default.
• W2019164040 hasConceptScore W2019164040C126322002 @default.
• W2019164040 hasConceptScore W2019164040C137627325 @default.
• W2019164040 hasConceptScore W2019164040C141071460 @default.
• W2019164040 hasConceptScore W2019164040C167135981 @default.
• W2019164040 hasConceptScore W2019164040C187212893 @default.
• W2019164040 hasConceptScore W2019164040C2777214474 @default.
• W2019164040 hasConceptScore W2019164040C2778230777 @default.
• W2019164040 hasConceptScore W2019164040C2778808290 @default.
• W2019164040 hasConceptScore W2019164040C2908647359 @default.
• W2019164040 hasConceptScore W2019164040C71924100 @default.
• W2019164040 hasConceptScore W2019164040C90924648 @default.
• W2019164040 hasConceptScore W2019164040C99454951 @default.
• W2019164040 hasIssue "39" @default.
• W2019164040 hasLocation W20191640401 @default.
• W2019164040 hasLocation W20191640402 @default.
• W2019164040 hasLocation W20191640403 @default.
• W2019164040 hasLocation W20191640404 @default.
• W2019164040 hasOpenAccess W2019164040 @default.
• W2019164040 hasPrimaryLocation W20191640401 @default.
• W2019164040 hasRelatedWork W151125730 @default.
• W2019164040 hasRelatedWork W1997565742 @default.
• W2019164040 hasRelatedWork W2044081255 @default.

• next